Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/48796
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2019-11-20T11:10:49Z-
dc.date.available2019-11-20T11:10:49Z-
dc.date.issued2017-09-
dc.identifier.citationVella, J., Wirth, F., Serracino-Inglott, A., & Azzopardi, L. M. (2017, September). Serum digoxin concentrations: clinical signals. Poster session presented at the 77th FIP Annual Conference, Seoul, Republic of Korea.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/48796-
dc.description.abstractA poster presentation regarding serum digoxin concentrations. Introduction: Digoxin, as a treatment option in cardiology, is limited by its narrow therapeutic index. • Current European Society of Cardiology (ESC) guidelines provide a Class 1 Level of Evidence B recommendation for digoxin in atrial fibrillation, and classify it as a treatment of uncertain benefit in heart failure. • Clinical guidelines recommend targeting a serum digoxin concentration (SDC) between 0.5 and 0.9 ng/ml, or <1.0 ng/ml. Aims: • To determine the number of patients on digoxin in Malta • To analyse SDCs recorded at Mater Dei Hospital (MDH) • To determine adherence to the clinically recommended target SDC • To assess queries concerning digoxin processed by the Drug Information Unit (DIU) at MDHen_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectDigoxinen_GB
dc.subjectDrug monitoring -- Research -- Maltaen_GB
dc.subjectCardiotonic agentsen_GB
dc.subjectHeart failure -- Chemotherapyen_GB
dc.subjectAtrial fibrillation -- Treatmenten_GB
dc.titleSerum digoxin concentrations : clinical signalsen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorVella, John-
dc.contributor.creatorWirth, Francesca-
dc.contributor.creatorSerracino-Inglott, Anthony-
dc.contributor.creatorAzzopardi, Lilian M.-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Serum_digoxin_concentrations_clinical_signals_2017.pdf814.01 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.